Hims & Hers Health, Inc. Class A Common Stock (HIMS)
57.13
-0.44 (-0.76%)
NYSE · Last Trade: Jun 12th, 3:45 PM EDT
When Wall Street turns bearish on a stock, it’s worth paying attention.
These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Via StockStory · June 12, 2025
The past six months have been a windfall for Hims & Hers Health’s shareholders. The company’s stock price has jumped 90%, hitting $57.16 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Via StockStory · June 12, 2025
If Hims were to align with Lilly, Citi warned, it would signal the company has "thrown in the towel" on compounded medications.
Via Stocktwits · June 11, 2025

Via Benzinga · June 4, 2025
Via The Motley Fool · June 8, 2025
Shares of Hims & Hers have crushed the market over the last year.
Via The Motley Fool · June 7, 2025
Via The Motley Fool · June 7, 2025

Hims & Hers stock is giving up some gains after announcing the acquisition of Zava, a European digital healthcare platform.
Via MarketBeat · June 5, 2025

Hims & Hers is expanding into Europe in a global push the company previewed earlier this year.
Via The Motley Fool · June 5, 2025

HIMS & HERS HEALTH INC (NYSE:HIMS) is a high-growth telehealth stock meeting Minervini’s Trend Template with strong earnings, revenue growth, and bullish technicals.
Via Chartmill · June 5, 2025

Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market reach by 2026.
Via Benzinga · June 4, 2025

Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns,
and those that can do all three for years on end are almost always the legendary stocks that return 100 times your money.
Via StockStory · June 4, 2025

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.
Via Chartmill · June 3, 2025

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.
Via Benzinga · June 3, 2025

The Zava acquisition will enable Hims & Hers to expand its footprint in the U.K. and launch operations in countries such as Germany, France, and Ireland, with other markets expected to follow soon.
Via Stocktwits · June 3, 2025

Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Tuesday after the company announced an acceleration of its global expansion through the acquisition of ZAVA.
Via Benzinga · June 3, 2025

The company hopes the deal will help it snag business in the UK, building a similar model to its U.S. platform.
Via Investor's Business Daily · June 3, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,
and over the past six months, the industry has pulled back by 12.9%. This drop was much worse than the S&P 500’s 1.9% loss.
Via StockStory · June 3, 2025